- Home
- APLT vs APWC Comparison
APLT vs APWC Comparison
Compare APLT & APWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- APWC
- Stock Information
- Founded
- APLT 2016
- APWC 1996
- Country
- APLT United States
- APWC Taiwan
- Employees
- APLT N/A
- APWC N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- APWC Telecommunications Equipment
- Sector
- APLT Health Care
- APWC Industrials
- Exchange
- APLT Nasdaq
- APWC Nasdaq
- Market Cap
- APLT 37.5M
- APWC 32.8M
- IPO Year
- APLT 2019
- APWC 1997
- Fundamental
- Price
- APLT $0.40
- APWC $1.61
- Analyst Decision
- APLT Buy
- APWC
- Analyst Count
- APLT 7
- APWC 0
- Target Price
- APLT $6.10
- APWC N/A
- AVG Volume (30 Days)
- APLT 1.9M
- APWC 6.1K
- Earning Date
- APLT 05-20-2025
- APWC 03-31-2025
- Dividend Yield
- APLT N/A
- APWC N/A
- EPS Growth
- APLT N/A
- APWC N/A
- EPS
- APLT N/A
- APWC 0.17
- Revenue
- APLT $455,000.00
- APWC $472,672,000.00
- Revenue This Year
- APLT $1,768.13
- APWC N/A
- Revenue Next Year
- APLT $361.28
- APWC N/A
- P/E Ratio
- APLT N/A
- APWC $9.46
- Revenue Growth
- APLT N/A
- APWC 11.02
- 52 Week Low
- APLT $0.30
- APWC $1.35
- 52 Week High
- APLT $10.62
- APWC $2.02
- Technical
- Relative Strength Index (RSI)
- APLT 46.92
- APWC 53.34
- Support Level
- APLT $0.39
- APWC $1.53
- Resistance Level
- APLT $0.44
- APWC $1.63
- Average True Range (ATR)
- APLT 0.04
- APWC 0.06
- MACD
- APLT 0.01
- APWC 0.00
- Stochastic Oscillator
- APLT 45.49
- APWC 50.25
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, PRC, Hong Kong and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.